Renoprotective Effects of Hydroxychloroquine and Folinic Acid via ET-1 and NLRP3 Modulation in Reducing Tubular Injury in A Rabbit Model of Methanol-induced Acute Kidney Injury
Abstract
BACKGROUND: Methanol intoxication is associated with significant morbidity and mortality, particularly when acute kidney injury (AKI) developed. Emerging evidence implicates Endothelin-1 (ET-1) and Nucleotide-binding domain leucine-rich repeat-containing pyrin receptor 3 (NLRP3) inflammasome in renal injury, but their roles in methanol-induced AKI remain unclear. To date, no studies have examined whether hydroxychloroquine or folinic acid, which are known to modulate ET-1 and NLRP3 signaling, could mitigate renal injury in this setting. This study evaluated their therapeutic effects in a rabbit model of methanol-induced AKI.
METHODS: The animals subjects were randomly assigned to four groups: control group receiving aquabidest, folinic acid group receiving 2 mg/kg body weight (BW) intraperitoneal folinic acid, hydroxychloroquine group receiving 30 mg/kg BW oral hydroxychloroquine phosphate, and combination group receiving both folinic acid and hydroxychloroquine at the same dosages. Histopathological evaluation of tubular injury scores and immunohistochemical analysis of ET-1 and NLRP3 expression were then conducted.
RESULTS: Expressions of ET-1, NLRP3, and tubular injury scores were significantly lower in the hydroxychloroquine, folinic acid, and combination therapy groups compared to the control group (p<0.001). Expression of ET-1 was lowest in folinic acid group (59.38±0.71%), followed by combination group (62.23±1.98%) and hydroxychloroquine group (62.43±1.81%), compared to control group (72.14±1.02%). Expression of NLRP3 was lowest in combination group (58.94±1.05%), followed by folinic acid and hydroxychloroquine group, which showed equal values (60.57±1.38%), compared to control group (72.15±1.02%). Tubular injury scores were also lowest in combination group (27.07±3.16%), followed by hydroxychloroquine group (45.29±1.75%) and folinic acid group (48.38±2.49%), compared to control group (77.15±1.66%).
CONCLUSION: Expression of ET-1 and NLRP3, as well as tubular injury scores, are significantly lower in all treatment groups compared to control, suggesting hydroxychloroquine and folinic acid demonstrated renoprotective effects in methanol-induced AKI, likely through modulation of ET-1 and NLRP3 pathways.
KEYWORDS: methanol intoxication, acute kidney injury, hydroxychloroquine, folinic acid, endothelin-1, NLRP3 inflammasome, experimental animal models, rabbits
Full Text:
PDFReferences
Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002; 40(4): 415-46, CrossRef.
Chang ST, Wang YT, Hou YC, Wang IK, Hong HH, Weng CH, et al. Acute kidney injury and the risk of mortality in patients with methanol intoxication. BMC Nephrol. 2019; 20(1): 205, CrossRef.
Verhelst D, Moulin P, Haufroid V, Wittebole X, Jadoul M, Hantson P. Acute renal injury following methanol poisoning: analysis of a case series. Int J Toxicol. 2004 Jul; 23(4): 267-73, CrossRef.
Verhelst D, Moulin P, Haufroid V, Wittebole X, Jadoul M, Hantson P. Acute renal injury following methanol poisoning: Analysis of a case series. Int J Toxicol. 2004; 23(4): 267-73, CrossRef.
De Miguel C, Speed JS, Kasztan M, Gohar EY, Pollock DM. Endothelin-1 and the kidney: New perspectives and recent findings. Curr Opin Nephrol Hypertens. 2016; 25(1): 35-41, CrossRef.
Meiliana A, Wijaya A. Metaflammation, NLRP3 inflammasome obesity and metabolic disease. Indones Biomed J. 2011; 3(3): 168-84, CrossRef.
Fan J, Xie K, Wang L, Zheng N, Yu X. Roles of inflammasomes in inflammatory kidney diseases. Mediators Inflamm. 2019; 2019: 2923072, CrossRef.
Zakharov S, Pelclova D, Urban P, Navratil T, Nurieva O, Kotikova K, et al. Use of out-of-hospital ethanol administration to improve outcome in mass methanol outbreaks. Ann Emerg Med. 2016; 68(1): 52-61, CrossRef.
Theobald J, Lim C. Folate as an adjuvant therapy in methanol poisoning. Nutr Clin Pract. 2019; 34(4): 521-7, CrossRef.
Suntoko B, Hadisaputro S, Kalim H, Hadi S, Warlisti IV. A double-blind, randomized controlled trial of hydroxychloroquine for cognitive dysfunction and inflammatory biomarkers in systemic lupus erythematosus patients in Indonesia. Indones Biomed J. 2023; 15(4): 354-61, CrossRef.
Zheng H, Zhang Y, He J, Yang Z, Zhang R, Li L, et al. Hydroxychloroquine inhibits macrophage activation and attenuates renal fibrosis after ischemia-reperfusion injury. Front Immunol. 2021; 12: 645100, CrossRef.
Pons-Estel GJ, Alarcón GS, McGwin G, Danila MI, Zhang J, Bastian HM, et al. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: Data from LUMINA, a multiethnic U.S. Cohort. Arthritis Rheum. Arthritis Rheum. 2009; 61(6): 830-9, CrossRef.
Wu CL, Chang CC, Kor CT, Yang TH, Chiu PF, Tarng DC, et al. Hydroxychloroquine use and risk of CKD in patients with rheumatoid arthritis. Clin J Am Soc Nephrol. 2018; 13(5): 702-9, CrossRef.
Sweeting JN, Siu M, McCallum GP, Miller L, Wells PG. Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates. Toxicol Appl Pharmacol. 2010; 247(1): 28-35, CrossRef.
Abdelkader RSE, El-Beih NM, Zaahkouk SA, El-Hussieny EA. Ameliorative effect of Eruca sativa seeds and its rutin on gentamicin‑induced nephrotoxicity in male rats via targeting inflammatory status, oxidative stress and kidney injury molecule-1 (KIM-1)/cystatin C expression. Indones Biomed J. 2022; 14(1): 74-83, CrossRef.
Dhaun N, Webb DJ, Kluth DC. Endothelin-1 and the kidney--beyond BP. Br J Pharmacol. 2012; 167(4): 720-31, CrossRef.
Wilhelm SM, Simonson MS, Robinson AV, Stowe NT, Schulak JA. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int. 1999; 55(3): 1011-8, CrossRef.
McMartin KE, Martin-Amat G, Makar AB, Tephly TR. Methanol poisoning. V. Role of formate metabolism in the monkey. J Pharmacol Exp Ther. 1977; 201(3): 564-72, CrossRef.
Bahadoram M, Keikhaei B, Saeedi-Boroujeni A, Mahmoudian-Sani M-R. Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19? Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(5): 997-1001, CrossRef.
Tang TT, Lv LL, Pan MM, Wen Y, Wang B, Li ZL, et al. Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis. 2018; 9(3): 351, CrossRef.
Deng H, Chen F, Wang Y, Jiang H, Dong Z, Yuan B, et al. The role of activated NLRP3 inflammatory body in acute kidney injury in rats caused by sepsis and NLRP3-TXNIP signaling pathway. Saudi J Biol Sci. 2020; 27(5): 1251-9, CrossRef.
McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008; 51(15): 1419-28, CrossRef.
Yasuda H, Leelahavanichkul A, Tsunoda S, Dear JW, Takahashi Y, Ito S, et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol. 2008; 294(5): F1050-8, CrossRef.
Sweeting JN, Siu M, Wiley MJ, Wells PG. Species- and strain-dependent teratogenicity of methanol in rabbits and mice. Reprod Toxicol. 2011; 31(1): 50-8, CrossRef.
Liesivuori J, Savolainen AH. Methanol and formic acid toxicity: biochemical mechanisms. Pharmacol Toxicol. 1991; 69(3): 157-63, CrossRef.
Abiola TS, David OO, Olatunde FE. Effect of tannin-rich extract of chasmanthera dependens on piroxicam-induced liver damage in male wistar rats. Mol Cell Biomed Sci. 2021; 5(1): 27-36, CrossRef.
DOI: https://doi.org/10.18585/inabj.v17i4.3747
Copyright (c) 2025 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
